Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Explore how patient experience data shapes regulatory drug decisions, enhancing the patient-focused drug development initiative for better treatment outcomes. Patient experience data are critical to ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The drug development process necessitates the comprehensive evaluation of a candidate’s therapeutic benefits alongside its potential risks. Benefit–risk assessments are central to this endeavour, ...

Find out how AI influences drug discovery, enabling earlier predictions and reducing the risks in clinical development.

Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

Mass Photometry (MP) and Macro Mass Photometry (MMP) are complementary, label-free techniques that analyze biomolecules and therapeutic vectors directly in solution with single-particle resolution.

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

Alex Zhavoronkov believes we’re cusp of what he calls “pharmaceutical superintelligence.” Courtesy of Insilico Medicine Zhavoronkov believes the industry is on the cusp of what he calls ...